2023Open access4cites
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority TrialVaccines, SARS-CoV-2 and COVID-19 Research
UniversitiesYousr Galaï
Active, last published 2026
0
H-index
0
Citations
Yousr has not officially claimed their profile. If you are Yousr, claim it free.
Claim Your Profile01 · About the work
What I study
research summary for Yousr Galaï will appear here once their profile is updated.
02 · Reach
Publication output and reach
Yousr's work has been cited 0 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
06 · Where I am
Affiliations
CurrentlyInstitut Pasteur
Research themes (UN SDGs)
07 · Selected work
Recent publications
2023Open access1cites
Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule with mRNA and Inactivated COVID-19 Vaccines: A Single-Blinded, Randomized, Parallel Group Superiority TrialSSRN Electronic Journal, SARS-CoV-2 and COVID-19 Research
2024
Anti-MOG spectrum disease or tuberculous meningomyelitis? About a caseClinica Chimica Acta, Infectious Diseases and Tuberculosis
2024Open access11cites
Exploring the landscape of symptom-specific inflammatory cytokines in post-COVID syndrome patientsBMC Infectious Diseases, Long-Term Effects of COVID-19
2024Open access
Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant PatientsVaccines, Immune responses and vaccinations
Are you Yousr?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required